Perchlorate

Perchlorate

SCHEMBL4886019

CCCCCCCCCC[n+]1c(/C=C/c2ccccc2O)ccc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.42
HTT P42858 9/20 0.42
MEN1 O00255 9/20 0.42
SMN1; SMN2 Q16637 8/20 0.42
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
KDM4E B2RXH2 6/20 0.42
NPSR1 Q6W5P4 5/20 0.42
LMNA P02545 4/20 0.42
MAPK1 P28482 4/20 0.42
RAD52 P43351 3/20 0.42
RGS12 O14924 1/20 0.42
USP2 O75604 1/20 0.42
HSP90AA1 P07900 1/20 0.42
THRB P10828 1/20 0.42
MCL1 Q07820 1/20 0.42
ACHE P22303 2/20 0.41
BCHE P06276 1/20 0.41
CHAT P28329 1/20 0.41
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perchlorate SCHEMBL4876095 0.88 KDM4E (0.44) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4876077 0.88 KDM4E (0.44) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4882254 0.84 KMT2A (0.44) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4882267 0.84 KMT2A (0.44) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4882186 0.83 ERN1 (0.38) KMT2AHTTMEN1SMN1; SMN2NPC1
SCHEMBL4881268 0.78 ACHE (0.42) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4882609 0.77 ACHE (0.58) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4882628 0.77 ACHE (0.58) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4883333 0.74 ALDH1A1 (0.42) KMT2AHTTMEN1SMN1; SMN2NPC1
Perchlorate SCHEMBL4883324 0.74 ALDH1A1 (0.42) KMT2AHTTMEN1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed
EP-1841428-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES Immusol Incorporated (US) 2007-10-10 EP disclosed
WO-2006078754-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES IMMUSOL INCORPORATED (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS KMT2A 944/4885HTT 2190/4885MEN1 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.